Clinical Trial Update: A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome [Phase 1]

View source ↗

Summary

This document reports that the Phase 1 PK/PD study of INV-202 in metabolic syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• INV-202

Snippet

Sponsor: Inversago Pharma Inc. | Conditions: Metabolic Syndrome | Phase 1 | Status: COMPLETED